tirzepatide cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed 🚨 New research presented at
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26












:max_bytes(150000):strip_icc():focal(742x196:744x198)/harvey-fierstein-122324-1-cc5047188eed46018a25b2702bc0deb7.jpg)






